Cutera Appoints Scott Ashworth as Executive Vice President of Global Sales
12/30/2013
Scott Ashworth recently joined Cutera as Executive Vice President of
Global Sales. He brings twenty-five years of experience in building and
leading global sales and marketing teams focused on commercialization
of products, establishing distribution partnerships, and other
leadership roles in medical technology companies. Scott started his
career as a sales representative at Hewlett Packard Medical Products
Group and then progressed to positions of increasing responsibility at
Acuson/Siemens, and Heartflow. Prior to joining Cutera, Scott was
Senior Vice President of Global Sales at Avinger.
Kevin Connors, President and CEO of Cutera, stated, "Scott's extensive multi-national, medical device management experience further strengthens our commercial leadership team as we continue to augment the strength of this part of our organization. Ollie Reese, Director of North American Sales, will continue to play a pivotal leadership role on Scott's team. Scott will initially be focused on the North American sales organization and will transition over time to assume international sales responsibilities. With our strengthened commercial leadership team, we are well positioned to capture an appropriate improved performance, given our existing broad product portfolio and planned new launches."
Kevin Connors, President and CEO of Cutera, stated, "Scott's extensive multi-national, medical device management experience further strengthens our commercial leadership team as we continue to augment the strength of this part of our organization. Ollie Reese, Director of North American Sales, will continue to play a pivotal leadership role on Scott's team. Scott will initially be focused on the North American sales organization and will transition over time to assume international sales responsibilities. With our strengthened commercial leadership team, we are well positioned to capture an appropriate improved performance, given our existing broad product portfolio and planned new launches."